JPS5384955A - Improvement in organic compound - Google Patents

Improvement in organic compound

Info

Publication number
JPS5384955A
JPS5384955A JP14648577A JP14648577A JPS5384955A JP S5384955 A JPS5384955 A JP S5384955A JP 14648577 A JP14648577 A JP 14648577A JP 14648577 A JP14648577 A JP 14648577A JP S5384955 A JPS5384955 A JP S5384955A
Authority
JP
Japan
Prior art keywords
improvement
organic compound
organic
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP14648577A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6214540B2 (de
Inventor
Puresu Yanosu
Zairaa Matsukusuupiitaa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of JPS5384955A publication Critical patent/JPS5384955A/ja
Publication of JPS6214540B2 publication Critical patent/JPS6214540B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58Radicals substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
JP14648577A 1976-12-07 1977-12-06 Improvement in organic compound Granted JPS5384955A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1535376 1976-12-07
CH8277 1977-01-05

Publications (2)

Publication Number Publication Date
JPS5384955A true JPS5384955A (en) 1978-07-26
JPS6214540B2 JPS6214540B2 (de) 1987-04-02

Family

ID=25683446

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14648577A Granted JPS5384955A (en) 1976-12-07 1977-12-06 Improvement in organic compound

Country Status (17)

Country Link
JP (1) JPS5384955A (de)
AT (1) AT366361B (de)
CA (1) CA1105475A (de)
DE (1) DE2752659A1 (de)
DK (1) DK527877A (de)
ES (1) ES464747A1 (de)
FI (1) FI773595A (de)
FR (1) FR2373513A1 (de)
GB (1) GB1597140A (de)
IE (1) IE45929B1 (de)
IL (1) IL53533A (de)
NL (1) NL7713364A (de)
NZ (1) NZ185884A (de)
PH (1) PH13932A (de)
PT (1) PT67365B (de)
SE (1) SE7713471L (de)
SU (1) SU927110A3 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992015553A1 (fr) * 1991-03-07 1992-09-17 Zeria Pharmaceutical Co., Ltd. Derive de trialkylamine et adjuvant de motilite de l'appareil digestif le contenant

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS639500B2 (de) * 1978-07-14 1988-02-29 Amerikan Hosupitaru Sapurai Corp
US4314082A (en) * 1978-07-14 1982-02-02 American Hospital Supply Corporation Derivatives of 2-amino-6,7-dihydroxytetrahydro naphthalene (ADTN)
EP0026848B1 (de) 1979-09-14 1983-05-04 Sandoz Ag Tetralinderivate, ihre Herstellung und Heilmittel, welche diese Verbindungen enthalten
EP0033789B1 (de) * 1980-01-30 1984-03-07 American Hospital Supply Corporation 2-alpha-Methyl-dopaminimino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalin, seine Salze, und Verfahren zu dessen Herstellung
SE8004002L (sv) * 1980-05-29 1981-11-30 Arvidsson Folke Lars Erik Terapeutiskt anvendbara tetralinderivat
IL65501A (en) * 1981-05-08 1986-04-29 Astra Laekemedel Ab 1-alkyl-2-aminotetralin derivatives,process for their preparation and pharmaceutical compositions containing them
WO1982004042A1 (en) * 1981-05-11 1982-11-25 Folke Lars Erik Arvidsson Therapeutically useful tetralin derivatives iii,processes for preparation and pharmaceutical preparations for such compounds
US4402974A (en) 1981-06-23 1983-09-06 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4559359A (en) * 1981-06-23 1985-12-17 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4455317A (en) * 1981-06-23 1984-06-19 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4454154A (en) * 1981-06-23 1984-06-12 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4578403A (en) * 1981-06-23 1986-03-25 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
IT1218322B (it) * 1982-06-10 1990-04-12 Chiesi Farma Spa Derivati di 1,2,3,4-tetraidronaftalene,procedimento di preparazione e relative composizioni farmaceutiche
US4500545A (en) * 1982-11-16 1985-02-19 Eli Lilly And Company Hydroxyaminotetralincarboxamides
US4448990A (en) * 1982-11-16 1984-05-15 Eli Lilly And Company Hydroxyaminotetralincarboxamides
US5177112A (en) * 1983-01-03 1993-01-05 Whitby Research, Inc. Substituted 2-aminotetralins
US4722933A (en) * 1985-12-20 1988-02-02 Nelson Research & Development Co. Substituted 2-aminotetralins
US4743618A (en) * 1983-01-03 1988-05-10 Nelson Research & Development Co. Substituted 2-aminotetralins
US4657925A (en) * 1984-08-13 1987-04-14 Nelson Research & Development Co. Method and compositions for reducing the intraocular pressure of mammals
US4564628A (en) * 1983-01-03 1986-01-14 Nelson Research & Development Co. Substituted 2-aminotetralins
GB2157950B (en) * 1984-05-04 1988-11-02 Nelson Res & Dev Selective d-2 dopamine receptor agonist
CA1331191C (en) 1988-03-25 1994-08-02 Bengt Ronny Andersson Therapeutically useful tetralin derivatives
US5214156A (en) * 1988-03-25 1993-05-25 The Upjohn Company Therapeutically useful tetralin derivatives
US5225596A (en) * 1989-01-09 1993-07-06 The Upjohn Company Halo substituted aminotetralins
JP2931986B2 (ja) * 1989-02-17 1999-08-09 武田薬品工業株式会社 アラルキルアミン誘導体
SE8901889D0 (sv) * 1989-05-26 1989-05-26 Astra Ab Novel 8-substituted-2-aminotetralines
SI0923542T1 (en) * 1996-05-31 2004-02-29 Pharmacia & Upjohn Company Aryl substituted cyclic amines as selective dopamine d3 ligands
IT1294931B1 (it) 1997-09-22 1999-04-23 Sigma Tau Ind Farmaceuti Derivati della 2-amminotetralina procedimento per la loro preparazione e composizioni farmaceutiche che li contengono, attive nella
AR054363A1 (es) * 2005-05-23 2007-06-20 Astrazeneca Ab Compuestos que exhiben actividad moduladora en el receptor 5-hidroxi-triptamina 6
EP2723727B1 (de) * 2011-06-27 2017-03-01 Shan Dong Luye Pharmaceutical Co., Ltd. Verfahren zur industriellen herstellung von stickstoffsubstituiertem amino-5,6,7,8-tetrahydronaphthol

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1017359A (en) * 1972-07-03 1977-09-13 Frederic P. Hauck Substituted cyclic polymethylene phenols

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992015553A1 (fr) * 1991-03-07 1992-09-17 Zeria Pharmaceutical Co., Ltd. Derive de trialkylamine et adjuvant de motilite de l'appareil digestif le contenant
US5380748A (en) * 1991-03-07 1995-01-10 Zeria Pharmaceutical Co., Ltd. Trialkylamine derivative and ameliorant for digestive tract movement containing the same

Also Published As

Publication number Publication date
FI773595A (fi) 1978-06-08
NZ185884A (en) 1980-04-28
PT67365B (fr) 1979-09-20
ES464747A1 (es) 1979-01-01
IL53533A (en) 1982-07-30
PH13932A (en) 1980-11-04
GB1597140A (en) 1981-09-03
FR2373513A1 (fr) 1978-07-07
NL7713364A (nl) 1978-06-09
DE2752659A1 (de) 1978-06-08
AT366361B (de) 1982-04-13
ATA871977A (de) 1981-08-15
DK527877A (da) 1978-06-08
CA1105475A (en) 1981-07-21
PT67365A (fr) 1978-01-01
FR2373513B1 (de) 1980-08-22
IL53533A0 (en) 1978-03-10
SE7713471L (sv) 1978-06-08
SU927110A3 (ru) 1982-05-07
IE45929B1 (en) 1982-12-29
IE45929L (en) 1978-06-07
JPS6214540B2 (de) 1987-04-02

Similar Documents

Publication Publication Date Title
JPS5384955A (en) Improvement in organic compound
JPS5356684A (en) Improvement concerning organic compound
JPS53119824A (en) Improvement in organic compound
JPS52116496A (en) Improvement in organic compound
JPS5287197A (en) Improvement in organic compound
JPS5395999A (en) Improvement in organic compound
JPS5392778A (en) Improvement in organic compound
JPS51142543A (en) Improvement in organic compound
JPS5340766A (en) Improvement in organic compound
JPS5285196A (en) Improvement in organic compound
JPS5332126A (en) Improvement in organic compound
JPS5384994A (en) Improvement in organic compound
JPS52139055A (en) Improvement in organic compound
JPS5297995A (en) Improvement in organic compound
JPS52139730A (en) Improvement in organic compound
JPS5377077A (en) Improvement in organic compound
JPS5318561A (en) Improvement in organic compound
JPS53119898A (en) Improvement in organic compound
JPS5257333A (en) Improvement in organic compound
JPS5312426A (en) Improvement in organic compound
JPS5344633A (en) Tmprovement in organic compound
JPS53103499A (en) Improvement in organic compound
JPS5377031A (en) Organic compound
JPS5283598A (en) Improvement in organic compounds
JPS52136169A (en) Improvement in organic compound